INTRODUCTION
============

Body mass index (BMI) is a simple anthropometric measure of nutritional status, but it is also an important mortality indicator among hospitalized patients \[[@r1]\]. In the elderly population, low BMI, which was defined as a BMI \<18.5 kg/m^2^, is more related to increased mortality than is being overweight \[[@r2], [@r3]\].

The serum albumin level is another important variable for assessing the nutritional status of patients with acute or chronic illness \[[@r4]\]. Hypoalbuminemia, defined as serum albumin levels \<3.5 g/dL, is common among hospitalized patients \[[@r5]\] and is associated with mortality and increased risk for various diseases \[[@r6]\], including heart failure \[[@r7]\], cirrhosis \[[@r8]\], and nephrotic syndrome \[[@r9]\]. In addition, poor functional recovery from stroke was noted in a population of patients with low BMIs and serum albumin levels \[[@r10]\]. This suggests, the combination of BMI and serum or urine albumin levels may be predictive of all-cause mortality in the general population \[[@r11]\].

Aging is a major risk factor adversely affecting life expectancy among the elderly \[[@r12], [@r13]\]. Many of these individuals have a limited performance status (Eastern Cooperative Oncology Group (ECOG) \[[@r14]\] score \>2) and use a wheelchair or are bedridden in long-term facilities. Indexes such as the Minimum Data Set (including: frailty index, nutrition, physical function and cognitive function) have been used to predict mortality in nursing homes \[[@r15]--[@r17]\]. However, most of those studies have focused on short-term mortality and used qualitative prognostic information instead of quantitative data \[[@r18]\]. We evaluated the utility of the combination of serum albumin and BMI for predicting mortality in elderly residents with limited performance status in long-term care facilities (ECOG score \>2) and assessed whether a cut-off value could assist physicians in clinical settings.

RESULTS
=======

In total, 228 individuals (42% men) living in eight different long-term care facilities met our inclusion criteria for BMI and serum albumin at the end of a 6-year follow-up period. Among those, 46 (20%) were excluded due to ECOG scores \<2 ([Figure 1](#f1){ref-type="fig"}). Of the remaining 182 participants, 20 (11%) had serum albumin levels \<2.8 g/dL, while 117 (64%) had serum albumin levels of 2.8--3.5 g/dL and 45 (25%) had levels \>3.5 g/dL. [Table 1](#t1){ref-type="table"} lists the basic characteristics of the participants segregated based on their albumin levels. The total number of deaths during follow-up was 139 (76%). The mean age of the participants with an ECOG score ≥2 was 78.8 years (57% women). Compared with the other two groups, participants with albumin levels \<2.8 g/dL were older and had a significantly lower waist circumference (WC) and BMI as well as lower hemoglobin, albumin, total cholesterol, and triglyceride (TG) levels.
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###### Comparison of population characteristics in different serum albumin concentrations

  ---------------------------------- ------------------------- -------------------- -------------- --------------- --------------
  **Variable**                       **Study group (n=182)**   **Albumin (g/dL)**   **\**P***                      
  **\<2.8 (n=20)**                   **2.8-3.5 (n=117)**       **\>3.5 (n=45)**                                    
   Age, years                        78.8 ± 7.5                83.6 ± 6.5           78.6 ± 7.5     77.1 ± 7.2      **0.0048**
   Female sex; % (n)                 57 (103)                  7 (7)                64 (66)        29 (30)         0.06
   Death; % (n)                      76 (139)                  14 (19)              64 (89)        22 (31)         0.07
   Systolic BP, mmHg                 127.0 ± 13.3              130.2 ± 12.2         126.4 ± 12.9   127.3 ± 14.7    0.5
   Diastolic BP, mmHg                75.3 ± 8.6                77.6 ± 7.5           75.2 ± 8.3     74.8 ± 9.9      0.4
   Waist circumference, cm           80.9 ± 10.1               74.2 ± 9.9           80.5 ± 9.6     84.7 ± 10.0     **0.0004**
   Body mass index, kg/m^2^          21.3 ± 4.1                18.3 ± 2.8           21.0 ± 3.      23.1 ± 4.3      **\<0.0001**
  Biochemistry                                                                                                     
   Hemoglobin, g/dL                  12.1 ± 1.9                10.6 ± 1.2           11.9 ± 1.8     13.1 ± 1.7      **\<0.0001**
   Albumin, g/dL                     3.2 ± 0.4                 2.5 ± 0.3            3.2 ± 0.2      3.7 ± 0.2       **\<0.0001**
   Glucose, mg/dL                    101.0 ± 29.3              95.8 ± 16.0          98.7 ± 21.1    109.2 ± 46.3    0.08
   Total cholesterol, mg/dL          178.4 ± 42.6              149.2 ± 36.1         175.5 ± 38.7   198.9 ± 46.1    **\<0.0001**
   Triglyceride, mg/dL               105.4 ± 108.1             79.1 ± 33.8          95.1 ± 63.4    143.9 ± 186.8   **0.018**
   High density lipoprotein, mg/dL   40.2 ± 11.0               36.6 ± 11.1          40.5 ± 10.7    41.1 ± 11.6     0.3
   Urin acid, mg/dL                  5.3 ± 1.7                 4.8 ± 1.5            5.1 ± 1.5      5.7 ± 2.1       0.06
   Blood urine nitrogen, mg/dL       16.6 ± 8.3                17.8 ± 8.5           16.3 ± 8.9     16.6 ± 6.4      0.8
   Creatinine, mg/dL                 1.0 ± 0.5                 1.0 ± 0.4            1.1 ± 0.6      1.0 ± 0.3       0.9
  Musculoskeletal conditions                                                                                       
  ECOG; % (n)                                                                                                      0.2
   2                                 25 (45)                   9 (4)                62 (28)        29 (13)         
   3                                 45 (81)                   9 (7)                62 (50)        30 (24)         
   4                                 31 (56)                   16 (9)               70 (39)        14 (8)          
  ---------------------------------- ------------------------- -------------------- -------------- --------------- --------------

BP: Blood Pressure; ECOG: Eastern Cooperative Oncology Group,

\*ANOVA for continuous variables, chi-square test for categorical variables for the different albumin concentration

In a univariate analysis, age, diastolic blood pressure (DBP), nutrition indices (i.e., WC, BMI, and albumin level), and renal function indices (i.e., blood urea nitrogen \[BUN\] and creatinine levels) were all associated with all-cause mortality (*P* \<0.05 for all; [Table 2](#t2){ref-type="table"}). In a multivariate analysis, participants with DBPs ≥90 mmHg had shorter survival times than those with DBPs \<90 mmHg (hazard ratio \[HR\] = 2.08; 95% confidence interval \[CI\] = 1.13-3.82; *P* = 0.018; [Table 2](#t2){ref-type="table"}). Moreover, mortality was higher among participants with BMIs \<18.5 kg/m^2^ and albumin levels \<2.8 g/dL than among those with BMIs of 18.5-24 kg/m^2^ and albumin levels \>3.5 g/dL (HR = 1.80, 95% CI = 1.11-2.94 and HR = 2.54, 95% CI 1.22-5.30, respectively; *P* = 0.018 and 0.013, respectively).

###### Cox regression models of mortality in elderly participants based on each covariate

  ---------------------------------------------- ------------------------- --------------- --------------------------- ------------ ---------- --------------- -------------
  **Individual covariates**                      **Univariate analysis**                   **Multivariate analysis**                                           
  **HR**                                         **95% CI**                ***P***         **HR**                      **95% CI**   ***P***                    
  Age, year                                      **1.04**                  **1.02-1.07**   **0.0002**                               1.03       1.00-1.06       0.089
  Gender Men vs women                            1.16                      0.83-1.63       0.377                                    1.10       0.66-1.85       0.709
  Systolic BP, mmHg                                                                                                                                            
   \<120                                         Reference                                                             Reference                               
   120-140                                       1.39                      0.95-2.03       0.087                                    1.43       0.86-2.38       0.17
   ≥140                                          1.20                      0.75-1.92       0.449                                    1.17       0.63-2.17       0.62
  Diastolic BP, mmHg                                                                                                                                           
   \<80                                          Reference                                                             Reference                               
   80-90                                         **0.59**                  **0.36-0.97**   **0.037**                                0.82       0.42-1.59       0.547
   ≥90                                           0.56                      0.28-1.15       0.115                                    **2.08**   **1.13-3.82**   **0.018**
  Waist circumference, cm ≥90/80 vs \<90/80\*    **0.70**                  **0.49-0.99**   **0.042**                                0.84       0.47-1.48       0.539
  BMI, kg/m^2^                                                                                                                                                 
   18.5-24                                       Reference                                                             Reference                               
   \<18.5                                        **1.81**                  **1.22-2.68**   **0.003**                                **1.80**   **1.11-2.94**   **0.018**
   24-27                                         1.03                      0.66-1.61       0.909                                    1.23       0.68-2.21       0.497
   ≥27                                           0.44                      0.19-1.01       0.052                                    0.39       0.14-1.07       0.068
  Hemoglobin. g/dL \<13.7/11.1 vs ≥13.7/11.1\*   1.39                      1.00-1.95       0.051                                    1.28       0.79-2.06       0.317
  Albumin, g/dL                                                                                                                                                
   \>3.5                                         Reference                                                             Reference                               
   2.8-3.5                                       1.35                      0.89-2.03       0.155                                    1.11       0.67-1.84       0.686
   \<2.8                                         **3.44**                  **1.93-6.14**   **\<0.0001**                             **2.54**   **1.22-5.30**   **0.013**
  Fasting glucose, mg/dL                                                                                                                                       
   \<100                                         Reference                                                             Reference                               
   100-126                                       1.04                      0.70-1.53       0.853                                    1.25       0.80-1.94       0.331
   ≥126                                          0.89                      0.52-1.54       0.679                                    1.11       0.56-2.21       0.759
  Total cholesterol, mg/dL \>200 vs ≤200         0.84                      0.57-1.24       0.378                                    1.02       0.64-1.63       0.94
  Triglyceride, mg/dL ≥150 vs \<150              1.08                      0.69-1.67       0.741                                    1.76       0.98-3.17       0.061
  HDL-C, mg/dL ≤40/50 vs \>40/50\*               0.98                      0.66-1.44       0.896                                    1.10       0.69-1.74       0.696
  BUN, mg/dL \>26 vs ≤26                         **3.67**                  **2.14-6.28**   **\<0.001**                              4.34       **2.03-9.30**   **\<0.001**
  Creatinine, mg/dL \>1.3/1.1 vs ≤1.3/1.1\*      **1.83**                  **1.24-2.70**   **0.002**                                1.06       0.58-1.93       0.853
  Uric Acid, mg/dL \>7.5/6.5 vs ≤7.5/6.5\*       1.37                      0.85-2.20       0.197                                    1.89       0.99-3.59       0.053
  ECOG score                                                                                                                                                   
   2                                             Reference                                                             Reference                               
   3                                             1.05                      0.68-1.62       0.829                                    0.80       0.48-1.32       0.374
   4                                             1.40                      0.89-2.20       0.144                                    1.52       0.84-2.72       0.164
  ---------------------------------------------- ------------------------- --------------- --------------------------- ------------ ---------- --------------- -------------

BP: Blood Pressure; BMI: Body Mass Index; HDL-C: High-density lipoprotein-Cholesterol; BUN: Blood urine nitrogen; ECOG: Eastern Cooperative Oncology Group.

\*Male/Female

From year 1 of the follow-up period onward, participants with both BMIs \<18.5 kg/m^2^ and albumin levels \<2.8 mg/dL had a lower survival rate ([Figure 2A](#f2){ref-type="fig"} and [2B](#f2){ref-type="fig"}). On the other hand, the survival rate did not differ significantly between participants with albumin levels of 2.8--3.5 mg/dL or \>3.5 mg/dL. The highest mortality was among participants with albumin levels \<2.8 mg/dL and BMIs \<18.5 kg/m^2^ (HR = 6.12, 95% CI = 1.85-20.21, *P* = 0.003; [Table 3](#t3){ref-type="table"}).

![Kaplan-Meier curves showing the effects of serum albumin levels (**A**) (P\<0.001) and BMI (**B**) (P\<0.001) on survival.](aging-12-102642-g002){#f2}

###### Multivariable adjusted Cox model in elderly patients at different BMIs and serum albumin levels with (A) DBP \<90 mmHg or (B) DBP \>90 mmHg

  ------------------ ------- ------------ -------------- ------- ------------- ------------ ------- ----------- ------------ ------- ---------- ------------
  **A**                                                                                                                                         
  **BMI, kg/m^2^**                                                                                                                              
                             **\<18.5**                          **18.5-24**                        **24-27**                        **\>27**   
                     \%      **HR**       **95%CI**      **%**   **HR**        **95%CI**    **%**   **HR**      **95%CI**    **%**   **HR**     **95%CI**
  Albumin, g/dL                                                                                                                                 
  \<2.8              3.8     6.12\*\*     1.85-20.21     4.9     3.40\*        1.25-9.28    0.5     2.65        0.29-24.05                      
  2.8-3.5            14.8    2.55\*       0.11-5.87      29.1    1.36          0.66-2.78    11      2.19        0.88-5.47    1.6     1.005      0.18-5.74
  \>3.5              2.7     4.01\*       1.09-14.75     9.9     Reference                  4.9     0.81        0.26-2.55    3.3     0.649      0.15-2.75
  **B**                                                                                                                                         
  **BMI, kg/m^2^**                                                                                                                              
                             **\<18.5**                          **18.5-24**                        **24-27**                        **\>27**   
                     **%**   **HR**       **95%CI**      **%**   **HR**        **95%CI**    **%**   **HR**      **95%CI**    **%**   **HR**     **95%CI**
  Albumin, g/dL                                                                                                                                 
  \<2.8              1.1     12.75\*\*    2.12-76.58     0.5     3.02          1.25-36.19                                                       
  2.8-3.5            2.7     1.13         0.27-4.81      3.3     3.45\*        1.06-11.19   0.5     4.76        1.47-48.21                      
  \>3.5              0.5     98.39\*\*    4.59-1126.33   1.1     2.58          0.28-23.67   1.6     5.50        1.13-26.80   0.5     5.25       1.49-55.80
  ------------------ ------- ------------ -------------- ------- ------------- ------------ ------- ----------- ------------ ------- ---------- ------------

\**P*\<0.05, \*\**P*\<0.01

DISCUSSION
==========

Low serum albumin levels not only increase the risk of postoperative organ dysfunction, they are also predictive of mortality in the healthy elderly \[[@r19], [@r20]\]. BMIs are inversely related to mortality in the elderly, and the combination of albumin level and BMI is used to predict risk of mortality in cardiac surgery and dialysis patients \[[@r21]--[@r23]\]. Our cohort study demonstrated that among elderly participants with limited performance status (ECOG ≥2), the mortality rate was 6-fold when the serum albumin level was \<2.8 mg/dL and BMI was \<18.5 kg/m^2^.

BMI
---

Low BMI (\<18.5 kg/m^2^) is predictive of mortality in the elder population. Large cohort studies of elders in Australia \[[@r24]\], Europe \[[@r25]\], and Taiwan \[[@r26]\] showed that being underweight associates with higher all-cause mortality risk. Similarly, we found an association between lower BMI and increased mortality risk in elders with limited musculoskeletal performance status ([Figure 2B](#f2){ref-type="fig"}). We also found that mortality among participants with BMIs \<18.5 kg/m^2^ and serum albumin levels \<2.8 g/dL is higher than among those with BMIs \<18.5 kg/m^2^ and albumin levels \>2.8 g/dL ([Table 3A](#t3){ref-type="table"}). This is consistent with the finding of Engelman et al. \[[@r22]\], who reported that elders with lower BMIs and serum albumin levels (\<2.8 g/dL) showed greater mortality than those with lower BMIs but normal serum albumin levels. This suggests that low BMI alone does not increase the risk of all-cause mortality.

Albumin
-------

A large cross-sectional longitudinal cohort study of a general elderly population (mean age = 73 years) found an association between albumin levels \<3.6 g/dL and higher mortality rates (HR = 2.8, 95% CI = 2.5-3.3) \[[@r26]\]. We found a similar association among limited-performance elders (mean age = 78.8 ± 7.5) when serum albumin levels were \<3.5 mg/dL ([Figure 2A](#f2){ref-type="fig"}). In addition, a low serum albumin level is a prognostic factor in cardiovascular disease \[[@r27]\], malnutrition \[[@r28]\], inflammatory reactions \[[@r29]\] and nephrotic syndrome \[[@r30]\] in elders. Similarly, we found that lower serum albumin levels associate with an increased risk of death (HR = 2.54, 95% CI = 1.22-5.30, *P* = 0.013) after adjusting for several potential confounders, including age, renal function, and BP ([Table 2](#t2){ref-type="table"}). Elderly patients undergoing surgical intervention are at higher risk than younger patients for such postoperative morbidities as pneumonia (OR = 1.76, 95% CI = 1.34-2.33, *P* \<0.001) and sepsis (OR = 2.29, 95% CI = 1.22-4.30, *P* = 0.010) \[[@r31]\]. Consequently, a lower serum albumin may reflect physiological impairments such as inflammation, malnutrition or malabsorption in older adults \[[@r32]\]. Importantly, the survival rate among older patients depends not only on the aforementioned physiological impairments, but also on such preexisting conditions as limited performance status, cognitive impairment, and low BMI \[[@r33]\].

Albumin and BMI
---------------

Combined low albumin levels and BMIs in the elderly associate with poor prognoses in several diseases \[[@r10], [@r34]--[@r37]\]. Mechanisms to explain lower serum albumin \[[@r35], [@r38]\] and BMI \[[@r39]\] may involve chronic inflammation, which appears to be a common factor in various diseases affecting the elderly, including cancer, cardiovascular disease, diabetes, cognitive impairment, frailty, sarcopenia \[[@r40], [@r41]\]. Compared to individuals without inflammation or obesity, patients exhibiting chronic inflammation have a greater risk of mortality \[HR = 2.68, 95%CI = 2.14-3.35\] when BMI is \<21.5 kg/m^2^ \[[@r42]\]. Moreover, inflammation may be the main cause of reduced serum albumin levels \[[@r43]\], and increasing the BMI can decrease the negative consequences of inflammation \[[@r42]\]. Our finding that mortality was highest when serum albumin was \<2.8 g/dL and BMI was \<18.5 kg/m^2^ is consistent with those earlier findings ([Table 3A](#t3){ref-type="table"}).

We also found that the risk of mortality increased about 2-fold in all categories of BMI and albumin when DBP was \>90 mmHg ([Table 3B](#t3){ref-type="table"}). Likewise, Athanase et al. reported that all-cause mortality in the elderly is increased when DBP is \>80 mmHg \[[@r44]\]. Thus, hypertension alone can increase the risk of all-cause mortality. However, a recent large prospective study of the general population reported that the combination of low-grade albuminuria and BMI predict mortality more accurately than low-grade albuminuria or BMI alone \[[@r11]\]. Our findings in elders with limited performance differs from those in middle aged individuals reported by Xiong et al. In elders, urinary tract infections and. cardiovascular diseases are common health conditions, and other conditions include musculoskeletal impairment, chronic obstructive pulmonary disease, cognitive impairment, cancer, diabetes mellitus, and inflammatory diseases \[[@r45]\]. Albuminuria can be affected by both physiological and abnormal stressors, such as exercise \[[@r46]\], posture \[[@r47]\], urinary tract infection \[[@r48]\], and myocardial ischemia \[[@r49]\]. Serum albumin is less affected by these conditions. For long-term medical care, therefore, combining BMI, albumin levels, and DBP as health condition indicators may be suitable for elderly individuals with limited performance status

Strengths and limitations
-------------------------

A key strength of our study is the relatively long follow-up period for elderly individuals with limited performance status. However, there were also several limitations. First, the number of participants was small. Second, the study did not use recent biological data or anthropometric indices. Therefore, changes in those factors could influence the results. Third, the height of some patients could not be measured, so arm length was used to estimate their BMI, which may have introduced bias into our results. Finally, because all of our participants were Taiwanese, our findings may not be applicable to other ethnic groups.

CONCLUSION
==========

Combined hypoalbuminemia (\<2.8 g/dL) and low BMI (\<18.5 kg/m^2^) may be a useful prognostic indicator for predicting high risk of mortality in elderly individuals with limited performance status (ECOG score ≥2). These findings could aid in early identification of relevant vulnerable populations.

MATERIALS AND METHODS
=====================

Participants
------------

The nutritional status of elderly individuals in long-term care facilities (NSELCF) study is an ongoing longitudinal cohort study, which recruited 374 \>65-year-old residents in eight long-term care facilities in Taiwan \[[@r50]\]. By the end of the follow-up on December 31, 2009, only 265 participants (men, 43.0%) remained. Of those, 37 were excluded because they had missing anthropometric or laboratory data, and 46 were excluded because they had ECOG scores \<2 ([Figure 1](#f1){ref-type="fig"}). Ultimately, 182 individuals were analyzed. Medical ethics approval for participant recruitment and data analyses was obtained from the Institutional Review Board of the China Medical University Hospital. All participants provided written informed consent.

Measurements
------------

The anthropometric indices included age, sex, weight (to the nearest 0.1 kg), height (to the nearest 0.1 cm), BMI (calculated as weight (kg) / estimated height squared (m^2^)), WC (to the nearest 0.1 cm), blood pressure (in mmHg), and ECOG score. The participants were divided into five categories from 0 (completely active) to 4 (completely disabled). For participants whose height measurement could not be directly measured, height was estimated based on arm span (length from the fingertips of one hand to those of the other hand \[[@r51]\]).

Blood was drawn while patients were in a lying or seated position. In addition to blood counts, the chemistry profile included creatinine, BUN, albumin, fasting glucose, cholesterol, TG, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and uric acid levels.

Mortality
---------

Mortality data were obtained from the Department of Health and Welfare in Taiwan from January 2003 to December 2009.

Statistical analysis
--------------------

Multivariable-adjusted Cox proportional hazards models were used to estimate HRs and 95% CIs. Anthropometric and laboratory data were categorized as follows: systolic blood pressure (≤120, 121--139, and ≥140 mmHg); DBP (≤80, 81--89, and ≥90 mmHg), BMI (≤18.5, 24--27, and ≥27 kg/m^2^); hemoglobin (male: \<13.7 and ≥13.7 g/dL; female: \<11.1 and ≥11.1 g/dL), albumin (\>3.5, 2.8--3.5, and \<2.8 g/dL), fasting glucose (≤100, 101-125, and ≥126 mg/dL), total cholesterol (\>200 and ≤200 mg/dL), TG (\>150 and ≤150 mg/dL), HDL-C (male: \>40 and ≤40 mg/dL; female: \>50 and ≤50 mg/dL), BUN (\>26 and ≤26 mg/dL), creatinine (male: \>1.3 and ≤1.3 mg/dL; female: \>1.1 and ≤1.1 mg/dL), and uric acid (male: \>7.5 and ≤7.5 mg/dL; female: \>6.5 and ≤6.5 mg/dL); and ECOG score (2, 3, and 4). ANOVA was used for continuous variables and the chi-square test was used for categorical variables at different albumin levels. Effects of albumin and BMI levels on mortality were determined using the Kaplan-Meier method. The mortality risk corresponding to different BMIs and albumin levels was also calculated. All statistical tests were two-sided, and values of *P* \<0.05 were considered significant. All statistical analyses were performed using the PC version of the SPSS statistical software (version 21.0; SPSS Inc., Chicago, IL, USA).
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